Thalidomide Analogs in Brazil: Concern About Teratogenesis
It has been more than 50 years since thalidomide was withdrawn from the world market due to its teratogenic potential. However, its widespread use around the world resumed due to its immunomo-dulatory and anti-angiogenic properties. The drug established itself in new therapies, and interest continue...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
2014-05-01
|
| Series: | Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia |
| Subjects: | |
| Online Access: | https://157.86.10.37/index.php/visaemdebate/article/view/230 |